Search >>
Sitemap >>
Contact >>
1350 I St. N.W.
Washington, DC
20005
tel: (202)898-5800
fax:(202)682-1639
|
 |
Katharine R. Latimer
|
Katharine R. Latimer
|
Ms. Latimer's complex litigation practice emphasizes the defense of pharmaceutical and medical device product liability and toxic tort claims. The National Law Journal has profiled three of her most significant victories as top defense wins of the year: Warren v. Sandoz Pharm. Corp. in 1998, Glastetter v. Novartis Pharm. Corp. in 2001, and Crowson v. Davol, Inc. in 2005.
Ms. Latimer represents manufacturers, premises owners, contractors, and other corporate members of highly regulated industries in trials and appeals of matters involving such products as prescription and over-the-counter drugs (including anxiety treatments, obstetrical drugs, antifungals, cough/cold medicines, diet aids, and cancer therapies), prostheses, welding rods, pesticides and herbicides, and manufacturing-use chemical compounds (including detergents, solvents and polychlorinated biphenyls (“PCBs”)). She is experienced in mass tort, class action and multi-jurisdiction litigation, and she serves as national trial counsel, regional trial counsel and Multidistrict Litigation (“MDL”) defense steering committee member in complex toxics matters. She also counsels clients on due diligence, product registration and labeling issues, as well as federal and state reporting requirements. Ms. Latimer has extensive experience in Daubert proceedings and the presentation and cross-examination of expert witnesses in diverse medical and technical fields. She represents our clients in their most high-profile litigation, including cases involving death, encephalopathy, brain, lung and breast cancer and cancer clusters, stroke, Parkinson’s disease, myocardial infarction, immunological injury, endocrine disruption, and myriad other serious injuries, as well as cases involving very substantial alleged business losses. These cases cover the gamut of liability theories, including fraud, conspiracy and other intentional torts. Ms. Latimer regularly coordinates amicus curiae support for our clients’ positions and frequently drafts amicus curiae briefs. She lectures at international and national seminars and private conferences on various aspects of pharmaceutical products liability and toxic tort litigation defense. She is the Consulting Editor and a member of the Advisory Board for the Expert Evidence Reporter published by BNA, and she was an inaugural member of the Lexis/Mealey's Toxic Tort Defense Advisory Council, on which she served until 2007. She served as an editorial board member of Mealey’s Litigation Reports: Toxic Torts from 1992 until 1995. She is a member of the Defense Research Institute (DRI). Ms. Latimer served as judicial clerk to the Hon. Johanna L. Fitzpatrick of the Nineteenth Judicial Circuit of Virginia (subsequently Chief Judge of the Virginia Court of Appeals).
|
|
